Drug Profile
Research programme: Chlamydia trachomatis vaccine - Prokarium
Latest Information Update: 24 Aug 2023
Price :
$50
*
At a glance
- Originator Prokarium
- Class Bacterial vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Chlamydial infections
Most Recent Events
- 24 Aug 2023 Discontinued - Preclinical for Chlamydial infections in United Kingdom (PO)
- 28 Oct 2019 No recent reports of development identified for preclinical development in Chlamydial-infections in United Kingdom (PO, Capsule)
- 21 Aug 2015 Preclinical trials in Chlamydial infections in United Kingdom (PO)